510(k) device
Collagen Wound Powder
Ventris Medical · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Jul 2, 2026, newest Jul 2, 2026BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
607
Naming "Collagen"
MAUDE reports
366
Brand "Collagen", since 2015
PubMed studies
257,093
Mentioning "Collagen"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Collagen Wound Powder510(k)
K260596 · Decided Jul 2, 2026 · 128 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Collagen Crosslinks, any MethodNational determinationOn the books190.19Updated Oct 1, 2026
- Collagen Meniscus ImplantNational analysisReview closedCAG-00414NUpdated Sep 17, 2026
- Collagen Meniscus ImplantNational determinationOn the books150.12Updated Jul 25, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Collagen", any status and sponsor, newest update first.
- Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®Not yet recruiting
University of California, IrvineAcademic, hospital or other
NCT07821112 · 20 participants (planned) · Start Dec 2026 · Primary completion Oct 2027
Device: GammaTile® · For: Glioma; Glioblastoma; GBM and 5 more
Sites: Orange, California
- Study of Collagen-Based Thrombin Hemostat for the Control of Bleeding in Spinal SurgeryPivotal-lookingCompleted
DALIM TISSEN Co., Ltd.Not on our public-company list
NCT07354178 · 130 participants · Start Oct 22, 2024 · Primary completion Jun 19, 2025
Device: CollaStat®; Floseal® · For: Spinal Tumor; Spinal Injury; Hemostasis and 3 more
Sites: Seoul, South Korea; Yongin-si, South Korea · 3 sites in all
- A Prospective, Multicenter, Controlled Clinical Study of Collagen Fibrous Scaffold for the Treatment of Cesarean Scar DiverticulumNot yet recruiting
Women's Hospital School Of Medicine Zhejiang UniversityAcademic, hospital or other
NCT07930689 · 82 participants (planned) · Start Nov 6, 2026 · Primary completion Nov 30, 2029
Device: collagen fibrous scaffold · For: Cesarean Scar Diverticulum; Abnormal Vaginal Bleeding; Fertility Impairment
Sites: Hangzhou, China
- Laser-Assisted Disinfection With and Without Photobiomodulation in Regenerative Endodontic Procedures for Necrotic Mature TeethNot yet recruiting
Future University in EgyptAcademic, hospital or other
NCT07931833 · 81 participants (planned) · Start Dec 1, 2026 · Primary completion Dec 2027
Device: 810 nm diode laser-assisted canal disinfection; Photobiomodulation (810 nm diode laser) · For: Mature Teeth; Endodontic Regeneration
Sites: Cairo, Egypt
Corza Medical GmbHNot on our public-company list
NCT07927413 · 600 participants (planned) · Start Feb 13, 2026 · Primary completion Nov 16, 2026
Device: DuraSeal® · For: Cerebrospinal Fluid (CSF) Leak; Psuedomeningocele
Sites: Baltimore, Maryland; New York, New York; Cincinnati, Ohio · 6 sites in all
University of Sao PauloAcademic, hospital or other
NCT07613775 · 40 participants (planned) · Start Oct 19, 2026 · Primary completion Oct 1, 2028
Device: Volume-stable xenogeneic collagen matrix (VCMX) · For: Gingival Recession
Sites: Ribeirão Preto, Brazil
- Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)Pivotal-lookingActive, not recruiting
GT Medical Technologies, Inc.Not on our public-company list
NCT04365374 · 230 participants (planned) · Start Apr 6, 2021 · Primary completion Aug 30, 2029
Device: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) · For: Brain Metastases
Sites: Phoenix, Arizona; Little Rock, Arkansas; Jacksonville, Florida · 37 sites in all
- Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CarePivotal-lookingRecruiting
GT Medical Technologies, Inc.Not on our public-company list
NCT07195591 · 766 participants (planned) · Start Dec 10, 2025 · Primary completion Dec 2031
Device: GammaTile® · For: Glioblastoma
Sites: Scottsdale, Arizona; Los Angeles, California; San Francisco, California · 22 sites in all
- Verifying the Effectiveness of the NUsurface® SystemPivotal-lookingCompleted
Phoenix KineticsNot on our public-company list
NCT02108496 · 337 participants · Start Jul 2014 · Primary completion Jun 2021
Device: NUsurface® Meniscus Implant · For: Meniscectomy; Osteoarthritis
Sites: Indianapolis, Indiana; Boston, Massachusetts; Roxbury Crossing, Massachusetts · 9 sites in all
- Alveolar Ridge Reconstruction in Post-extraction Sites Using a Magnesium Resorbable Membrane. An Explorative StudyActive, not recruiting
Martina StefaniniAcademic, hospital or other
NCT07646795 · 10 participants · Start Nov 27, 2024 · Primary completion Nov 27, 2026
Device: NOVAMag® · For: Bone Augmentation; Alveolar Ridge Augmentation
Sites: Bologna, Italy
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Collagen", and for the whole product code for context.
This brand
366 reports: 23 malfunction, 330 injury, 8 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
MW6004157 · Received Oct 16, 2026 · Event dated Oct 5, 2026
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Skin Inflammation/ Irritation; Contact Dermatitis
2249852-2026-00013 · Received Sep 17, 2026 · Event dated Nov 2, 2025
Device type: Dura Substitute (GXQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
2249852-2026-00012 · Received Sep 17, 2026 · Event dated Jun 28, 2025
Device type: Dura Substitute (GXQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Erythema; Hallucination; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
2249852-2026-00015 · Received Sep 17, 2026 · Event dated Oct 3, 2025
Device type: Dura Substitute (GXQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
2249852-2026-00014 · Received Sep 17, 2026 · Event dated Sep 22, 2025
Device type: Dura Substitute (GXQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Memory Loss/Impairment; Confusion/ Disorientation
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Collagen"[tiab]. The summary above synthesizes these.
- Collagen study advances for photoaging skin.
Liu H, Dong J, Du R, et al. · Photodermatol Photoimmunol Photomed · 2024Review
- Collagen Mimetic Peptides.
Xu Y, Kirchner M · Bioengineering (Basel) · 2021Review
- Collagen biosynthesis.
Last JA, Reiser KM · Environ Health Perspect · 1984Review
- Marine Collagen: A Promising Biomaterial for Wound Healing, Skin Anti-Aging, and Bone Regeneration.
Geahchan S, Baharlouei P, Rahman A · Mar Drugs · 2022Review
- Structure of Collagen.
Zhao C, Xiao Y, Ling S, et al. · Methods Mol Biol · 2021Research Support, Non-U.S. Gov't
- Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffness.
Li Q, He XL, Chen SJ, et al. · J Clin Invest · 2025Research Support, Non-U.S. Gov't
- The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials.
Asserin J, Lati E, Shioya T, et al. · J Cosmet Dermatol · 2015Randomized Controlled Trial
- Engineered Collagen Matrices.
Patil VA, Masters KS · Bioengineering (Basel) · 2020Review
- Collagen Quantification in Tissue Specimens.
Coentro JQ, Capella-Monsonís H, Graceffa V, et al. · Methods Mol Biol · 2017Research Support, Non-U.S. Gov't
- Collagen modifications.
Arem A · Clin Plast Surg · 1985Review
- Prokaryotic Collagen-Like Proteins as Novel Biomaterials.
Picker J, Lan Z, Arora S, et al. · Front Bioeng Biotechnol · 2022Review
- Calcium concentration dependent collagen mineralization.
Niu X, Fan R, Tian F, et al. · Mater Sci Eng C Mater Biol Appl · 2017
Other devices of this type
Also filed under product code KGN.
- Cytal® Wound MatrixAcell, Inc. · 510(k) 2024
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.